Redmile Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.31M | Sell |
740,261
-466,903
| -39% | -$5.24M | 0.88% | 26 |
|
|
2025
Q1 | $5.52M | Sell |
1,207,164
-111,000
| -8% | -$507K | 0.52% | 36 |
|
|
2024
Q4 | $7.43M | Sell |
1,318,164
-65,202
| -5% | -$368K | 0.52% | 39 |
|
|
2024
Q3 | $6.7M | Sell |
1,383,366
-80,040
| -5% | -$387K | 0.39% | 43 |
|
|
2024
Q2 | $7.14M | Sell |
1,463,406
-141,109
| -9% | -$689K | 0.43% | 44 |
|
|
2024
Q1 | $21.3M | Sell |
1,604,515
-114,154
| -7% | -$1.52M | 0.78% | 40 |
|
|
2023
Q4 | $24M | Buy |
1,718,669
+908,892
| +112% | +$12.7M | 0.86% | 35 |
|
|
2023
Q3 | $10.7M | Sell |
809,777
-252,183
| -24% | -$3.34M | 0.51% | 42 |
|
|
2023
Q2 | $19.9M | Sell |
1,061,960
-58,719
| -5% | -$1.1M | 0.76% | 38 |
|
|
2023
Q1 | $16.2M | Sell |
1,120,679
-101,224
| -8% | -$1.46M | 0.7% | 46 |
|
|
2022
Q4 | $23.6M | Sell |
1,221,903
-283,223
| -19% | -$5.48M | 0.97% | 31 |
|
|
2022
Q3 | $51.7M | Sell |
1,505,126
-328,421
| -18% | -$11.3M | 2.01% | 17 |
|
|
2022
Q2 | $28M | Sell |
1,833,547
-1,781
| -0.1% | -$27.2K | 1.07% | 26 |
|
|
2022
Q1 | $41.9M | Buy |
1,835,328
+126,792
| +7% | +$2.89M | 1.31% | 23 |
|
|
2021
Q4 | $63M | Sell |
1,708,536
-160,494
| -9% | -$5.92M | 1.43% | 17 |
|
|
2021
Q3 | $87.8M | Sell |
1,869,030
-67,500
| -3% | -$3.17M | 1.53% | 23 |
|
|
2021
Q2 | $117M | Buy |
+1,936,530
| New | +$117M | 1.73% | 18 |
|